Important Safety Information Regarding Carpuject Syringe System? Potential Overfill
Posted Friday, May 18, 2012Hospira is issuing this Important Safety Information letter to alert Healthcare Professionals to the potential overfill of volume amounts in the pre-filled Carpuject syringe system. This also includes the 2 mL iSecure presentations of midazolam and ondansetron. Hospira has received reports of Carpuject syringes containing more than the labeled fill volume of medication than is stated on the label. See attached for list of affected products and lots.